Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
Regulatory Info :
Registration Country : Ukraine
Brand Name : Apsorbin
Dosage Form : Powder for Oral Suspension
Dosage Strength :
Packaging : 3G Sachet
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Ukraine
Regulatory Info :
Registration Country : Vietnam
Brand Name : Smetstad
Dosage Form : Oral powder
Dosage Strength : 3G
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Vietnam
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
Regulatory Info :
Registration Country : Ukraine
Brand Name : Apsorbin
Dosage Form : Powder for Oral Suspension
Dosage Strength :
Packaging : 3G Sachet
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Ukraine
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Dossiers
Regulatory Info :
Registration Country : Vietnam
Brand Name : Smetstad
Dosage Form : Oral powder
Dosage Strength : 3G
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Vietnam
Packaging :
Regulatory Info :
Dosage : Oral powder
Dosage Strength : 3G
Brand Name : Smetstad
Approval Date :
Application Number :
Registration Country : Vietnam
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Global Sales Information
Annual Reports
Main Therapeutic Indication : Gastrointestinal Disorders
Currency : USD
2020 Revenue in Millions : 98
2019 Revenue in Millions : 152
Growth (%) : -36
Main Therapeutic Indication : Gastrointestinal Disorders
Currency : USD
2021 Revenue in Millions : 98
2020 Revenue in Millions : 98
Growth (%) : 10
Main Therapeutic Indication : Others
Currency : USD
2015 Revenue in Millions : 133
2014 Revenue in Millions : 127
Growth (%) : -5%
Main Therapeutic Indication : Gastrointestinal Disorders
Currency : USD
2016 Revenue in Millions : 118
2015 Revenue in Millions : 122
Growth (%) : -3
Main Therapeutic Indication : Gastrointestinal Disorders
Currency : USD
2017 Revenue in Millions : 143
2016 Revenue in Millions : 138
Growth (%) : 4
Main Therapeutic Indication : Gastrointestinal Disorders
Currency : USD
2018 Revenue in Millions : 143
2017 Revenue in Millions : 140
Growth (%) : 2%
Main Therapeutic Indication : Others
Currency : USD
2014 Revenue in Millions : 2.70%
2013 Revenue in Millions :
Growth (%) :
Main Therapeutic Indication : Gastrointestinal Disorders
Currency : USD
2019 Revenue in Millions : 137
2018 Revenue in Millions : 138
Growth (%) : -1
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
ABOUT THIS PAGE
